Biomedical Engineering Reference
In-Depth Information
Shingu-Vazquez M, Traven A (2011) Mitochondria and fungal pathogenesis: drug tolerance,
virulence, and potential for antifungal therapy. Eukaryot Cell 10:1376-1383
Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J (2011) Adherence and
biofilm formation of non-
Candida albicans
Candida species. Trends Microbiol 19:241-247
Singh A, Mahto KK, Prasad R (2013) Lipidomics and in vitro azole resistance in
Candida
albicans
. OMICS 17(2):84-93
Smriti, Krishnamurthy S, Dixit, BL, Gupta CM, Milewski S, Prasad R (2002) ABC transporters
Cdr1p, Cdr2p and Cdr3p of a human pathogen
Candida albicans
are general phospholipid
translocators. Yeast 19:303-318
St Georgiev V (2000) Membrane transporters and antifungal drug resistance. Curr Drug Targets
1:261-284
Stephanie SP, Paulsen IT, Saier MH Jr (1998) Major facilitator superfamily. Microbiol Mol Biol
Rev 62:1-34
Sun N, Fonzi W, Chen H, She X, Zhang L, Zhang L et al (2013) Azole susceptibility and
transcriptome profiling in
Candida albicans
mitochondrial electron transport chain complex
I mutants. Antimicrob Agents Chemother 57:532-542
Talibi D, Raymond M (1999) Isolation of a putative
Candida albicans
transcriptional regulator
involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation
in
Saccharomyces cerevisiae
. J Bacteriol 181:231-240
Torelli R, Posteraro B, Ferrari S, La Sorda M, Fadda G, Sanglard D et al (2008) The ATP-binding
cassette transporter-encoding gene
CgSNQ2
is contributing to the
CgPDR1
-dependent azole
resistance of
Candida glabrata
. Mol Microbiol 68:186-201
Tuch BB, Galgoczy DJ, Hernday AD, Li H, Johnson AD (2008) The evolution of combinatorial
gene regulation in fungi. PLoS Biol 6:e38
Uppuluri P, Srinivasan A, Ramasubramanian A, Lopez-Ribot JL (2011) Effects of fluconazole,
amphotericin B, and caspofungin on
Candida albicans
biofilms under conditions of flow and
on biofilm dispersion. Antimicrob Agents Chemother 55:3591-3593
Vanden Bossche H, Marichal P, Gorrens J, Coene MC, Willemsens G, Bellens D et al (1989)
Biochemical approaches to selective antifungal activity: focus on azole antifungals. Mycoses
32:35-52
Vandeputte P, Tronchin G, Berg`s T, Hennequin C, Chabasse D, Bouchara JP (2007) Reduced
susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical
isolate of
Candida glabrata
with pseudohyphal growth. Antimicrob Agents Chemother
51:982-990
Vandeputte P, Pradervand S, Ischer F, Coste AT, Ferrari S, Harshman K et al (2012) Identification
and functional characterization of Rca1, a transcription factor involved in both antifungal
susceptibility and host response in
Candida albicans
. Eukaryot Cell 11:916-931
Vinces MD, Haas C, Kumamoto CA (2006) Expression of the
Candida albicans
morphogenesis
regulator gene
CZF1
and its regulation by Efg1p and Czf1p. Eukaryot Cell 5:825-835
Wang H, Kong F, Sorrell TC, Wang B, McNicholas P, Pantarat N et al (2009) Rapid detection of
ERG11
gene mutations in clinical
Candida albicans
isolates with reduced susceptibility to
fluconazole by rolling circle amplification and DNA sequencing. BMC Microbiol 14:167
White TC, Silver PM (2005) Regulation of sterol metabolism in
Candida albicans
by the
UPC2
gene. Biochem Soc Trans 33:1215-1218
White TC, Holleman S, Dy F, Mirels LF, Stevens DA (2002) Resistance mechanisms in clinical
isolates of
Candida albicans
. Antimicrob Agents Chemother 46:1704-1713
Young LY, Hull CM, Heitman J (2003) Disruption of ergosterol biosynthesis confers resistance to
amphotericin B in
Candida lusitaniae
. Antimicrob Agents Chemother 47:2717-2724
Znaidi S, Weber S, Al-Abdin OZ, Bomme P, Saidane S, Drouin S et al (2008) Genomewide
location analysis of
Candida albicans
Upc2p, a regulator of sterol metabolism and azole drug
resistance. Eukaryot Cell 7:836-847
Znaidi S, Barker KS, Weber S, Alarco AM, Liu TT, Boucher G et al (2009) Identification of the
Candida albicans
Cap1p regulon. Eukaryot Cell 8:806-820
Search WWH ::
Custom Search